As New York advocates await final action on legislation to remove prior authorization requirements for medications to treat opioid use disorder, a new report projects major cost savings from such a move.
Dexter Braff, MBA, MS, told Treatment Center Investment & Valuation Retreat attendees that with private equity investors pouring money into the autism space, there’s an opportunity for strategic investors to create a competitive advantage.
Compared with US adults who have never used electronic cigarettes (e-cigarettes), those who have used e-cigarettes had higher odds of reporting a history of a clinical diagnosis of depression, according to a study of nearly 900,000 people.
Pimavanserin, currently approved by the US Food and Drug Administration (FDA) for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis, reduced the risk of psychosis relapse 2.8-fold in patients with dementia.
For any human services provider, your workforce is your most strategic asset. Providing exceptional care starts with exceptional clinicians. What’s the secret to exceptional clinicians? It starts with how satisfied and engaged they are in their job.